SCHEMBL4069104

SCHEMBL4069104

[CH2]c1ccc(S(=O)(=O)N(CC)CC)cc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.70
HTT P42858 4/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
NPC1 O15118 1/20 0.63
RAB9A P51151 1/20 0.63
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
KDM1A O60341 1/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
ALDH1A1 P00352 5/20 0.52
TSHR P16473 1/20 0.52
MAPT P10636 2/20 0.51
VCAM1 P19320 1/20 0.50
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081266 0.84 CA9 (0.62) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL23057256 0.81 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL10592845 0.81 LMNA (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5023540 0.81 HTT (0.73) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL3265384 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL2932439 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL23043651 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL5024746 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL3314209 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A
SCHEMBL810965 0.79 LMNA (0.70) LMNAHTTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117577-A1 G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF GABA-RELATED NEUROLOGICAL DISORDERS INCLUDING SLEEP-RELATED DISORDERS Arena Pharmaceuticals, Inc. (US) 2009-11-18 EP disclosed
WO-2008085888-A1 G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF GABA-RELATED NEUROLOGICAL DISORDERS INCLUDING SLEEP-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2008-07-17 WO disclosed